North America:
The benzodiazepine market in North America is well-established, driven by a high prevalence of anxiety disorders, insomnia, seizures, and muscle spasms. The United States and Canada are the major markets in this region, benefiting from a large patient population, advanced healthcare infrastructure, and a high rate of diagnosis and treatment of mental health conditions. The demand...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian